E-LIB Suche - Ergebnisse für: Natanegara, Fanni

1

Decision making in clinical trials: Interim analyses, innov..:

Welsh‐Bohmer, Kathleen A. ; Kerchner, Geoffrey A. ; Dhadda, Shobha...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 9 (2023) 4 - p. , 2023

Link: https://doi.org/10.1002/..

2

Design and Execution of Sustainable Decentralized Clinical ..:

Singh, Pritibha ; Burden, Andrea M. ; Natanegara, Fanni.
Clinical Pharmacology & Therapeutics. 114 (2023) 4 - p. 802-809 , 2023

Link: https://doi.org/10.1002/..

3

Advancing innovative clinical trials to efficiently deliver..:

Beckman, Robert A. ; Natanegara, Fanni ; Singh, Pritibha...
Nature Reviews Drug Discovery. 21 (2022) 8 - p. 543-544 , 2022

Link: https://doi.org/10.1038/..

4

Evaluation of the performance of alternative models in anal..:

Wang, Guoqiao ; Li, Yan ; Xiong, Chengjie...
Alzheimer's & Dementia. 18 (2022) S10 - p. , 2022

Link: https://doi.org/10.1002/..

5

Why are There not More Bayesian Clinical Trials? Ability to..:

The Medical Outreach Team of the Drug Information Association Bayesian Scientific Working Group ; Bray, Ross ; Hartley, Andrew...
Therapeutic Innovation & Regulatory Science. 57 (2022) 3 - p. 426-435 , 2022

Link: https://doi.org/10.1007/..

6

Why are not There More Bayesian Clinical Trials? Perceived ..:

The Medical Outreach Subteam of the Drug Information Association Bayesian Scientific Working Group ; Clark, Jennifer ; Muhlemann, Natalia...
Therapeutic Innovation & Regulatory Science. 57 (2022) 3 - p. 417-425 , 2022

Link: https://doi.org/10.1007/..

7

Phase II (NAVIGATE-AD study) Results of LY3202626 Effects o..:

Lo, Albert C. ; Evans, Cynthia Duggan ; Mancini, Michele...
Journal of Alzheimer's Disease Reports. 5 (2021) 1 - p. 321-336 , 2021

Link: https://doi.org/10.3233/..

8

Statistical Opportunities to Accelerate Development for COV..:

Natanegara, Fanni ; Zariffa, Névine ; Buenconsejo, Joan...
Statistics in Biopharmaceutical Research. 14 (2021) 1 - p. 5-21 , 2021

Link: https://doi.org/10.1080/..

9

Donanemab (LY3002813) dose‐escalation study in Alzheimer's ..:

Lowe, Stephen Loucian ; Willis, Brian A. ; Hawdon, Anne...
Alzheimer's & Dementia: Translational Research & Clinical Interventions. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1002/..

10

Brain target occupancy of LY3372689, an inhibitor of the O‐..:

Shcherbinin, Sergey ; Kielbasa, William ; Dubois, Susan...
Alzheimer's & Dementia. 16 (2020) S4 - p. , 2020

Link: https://doi.org/10.1002/..

11

A single ascending dose study in healthy volunteers to asse..:

Kielbasa, William ; Phipps, Krista M ; Tseng, James...
Alzheimer's & Dementia. 16 (2020) S9 - p. , 2020

Link: https://doi.org/10.1002/..

12

P1‐048: PLASMA NF‐L AS A BIOMARKER FOR NEURODEGENERATION IN..:

Wang, Hong ; Charil, Arnaud ; Shcherbinin, Sergey...
Alzheimer's & Dementia. 15 (2019) 7S_Part_4 - p. , 2019

Link: https://doi.org/10.1016/..

13

P3‐026: IMPLEMENTATION OF DUAL‐PHASE FLORBETAPIR PET IN THE..:

Shcherbinin, Sergey ; Hesterman, Jacob ; Devous Sr., Michael D....
Alzheimer's & Dementia. 15 (2019) 7S_Part_18 - p. , 2019

Link: https://doi.org/10.1016/..

14

Bayesian methods for the design and analysis of noninferior..:

Gamalo-Siebers, Margaret ; Gao, Aijun ; Lakshminarayanan, Mani...
Journal of Biopharmaceutical Statistics. 26 (2016) 5 - p. 823-841 , 2016

Link: https://doi.org/10.1080/..

15

Estimation of the inter- and intrasubject variability of th..:

Natanegara, Fanni ; Tran, Adrienne ; Lowe, Stephen..
Int. Journal of Clinical Pharmacology and Therapeutics. 53 (2015) 3 - p. 199-205 , 2015

Link: https://doi.org/10.5414/..